rdkriplani

Astec Lifesciences - Results play

NSE:ASTEC   ASTEC LIFESCIENCES
The stock has been backward integrating as a strategy. Pre Covid the company had its best result in along time. There could be a revival again this quarter. Results are on 29th Oct.

Technically the stock could be breaking out after consolidating for an entire quarter. Long at CMP with stoploss below 1050.

Fundamentally expecting a 100% YOY growth in profits this quarter.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。